We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App




Endoscopic Ablation System Eradicates Barrett’s Esophagus

By Theresa Herman
Posted on 02 May 2016
A novel radio frequency ablation (RFA) catheter simplifies circumferential ablation of Barrett’s esophagus (BE), as well as reducing procedure time by up to 20%.

The Barrx 360 Express RFA balloon catheter uses a proprietary bipolar electrode array set in a soft, compliant balloon material to provide a 360-degree, three-centimeter long ablation zone that delivers precise circumferential RFA energy to the targeted BE tissue area. More...
The procedure involves several steps: first, a soft sizing balloon is introduced to measure the diameter of the esophagus. The Barrx 360 RFA is then introduced over a guidewire, and the ablative energy is delivered, with the catheter moved distally to treat all targeted tissue. Focal catheters can be used for residual disease touch-up.

Components of the system include a proprietary RFA energy generator that automatically inflates to the appropriate size, based on the patient’s esophagus; sets the ablation parameters; and supplies energy to the soft sizing balloon and the RFA balloon catheter. The coagulum is removed from the ablation zone with a cleaning cap mounted on the endoscope. The Barrx 360 Express RFA is a product of Medtronic (Dublin, Ireland), and is available in five sizes, ranging from 18-31 mm.

“The biggest advantage of the Barrx 360 Express catheter is that it’s easier to use because of the larger, longer, and adjustable balloon size,” said Anthony Infantolino, MD, of Thomas Jefferson University Hospital (Philadelphia, PA, USA). “These new features provide for a reduction in surgery time and the number of catheters required during RFA procedures, allowing me to concentrate on increasing the quality of the procedure.”

BE refers to an abnormal change (metaplasia) in the cells of the lower portion of the esophagus, when the normal squamous epithelium lining of the esophagus is replaced by goblet cells, which are usually found lower in the GI tract. The medical significance of Barrett esophagus is its strong association with esophageal adenocarcinoma, a particularly lethal form of cancer.

Related Links:
Medtronic
Thomas Jefferson University Hospital

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Endoscopy Display
E190
New
Dual Chamber Warming Cabinet
D-Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.